Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Immunomedics files IND for humanized lymphoma antibody

May 7, 1997

Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders

April 28, 1997

Altarex receives funding for photodynamic therapy for ovarian cancer research

April 28, 1997

Bioniche reports positive clinical results for Regressin

April 25, 1997

BTG licenses Campath-1H to LeukoSite

April 25, 1997

Cel-Sci initiates clinical trial of Multikine in Israel

April 24, 1997

Medarex presents MDX-220 preclinical data at AACR

April 21, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Antitumor activity of Ono-4007 related to TNF induction

April 7, 1997

CAT and Techniclone to initiate trials for tumor therapy

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...